logo
Select company
Select metric
17.37%Cash to Assets Ratio
VS
Market
71
Sector
40
Industry
27
History
42
$ 27.98Close
$ 6.28 - $ 27.98 52-Week Range
Ticker Information

Ticker

NTLA

Company Name

INTELLIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INTELLIA THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NTLA - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 898.89M$ 156.17M17.37%
3/31/2025$ 986.16M$ 126.88M12.87%
12/31/2024$ 1.19B$ 189.18M15.88%
9/30/2024$ 1.17B$ 120.5M10.27%
6/30/2024$ 1.19B$ 130.85M10.98%
3/31/2024$ 1.26B$ 171.98M13.65%
12/31/2023$ 1.3B$ 226.75M17.43%
9/30/2023$ 1.24B$ 168.03M13.51%
6/30/2023$ 1.32B$ 171.81M12.98%
3/31/2023$ 1.42B$ 294.15M20.75%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INTELLIA THERAPEUTICS INC's latest trailing twelve months (TTM) Cash to Assets stands at 39.2%.
  • Over the past 5 years, INTELLIA THERAPEUTICS INC's average Cash to Assets has been 17.7%.
  • The median Cash to Assets for INTELLIA THERAPEUTICS INC during this period was 14.77%
  • INTELLIA THERAPEUTICS INC reached its highest Cash to Assets over the past 5 years at 39.2%.
  • The lowest Cash to Assets recorded by INTELLIA THERAPEUTICS INC in the same timeframe 9.53%

INTELLIA THERAPEUTICS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
ABCL : ABCELLERA BIOLOGICS INC 8.38%EYPT : EYEPOINT PHARMACEUTICALS INC 23.67%ZVRA : ZEVRA THERAPEUTICS INC 18.62%BEAM : BEAM THERAPEUTICS INC 20.76%MGTX : MEIRAGTX HOLDINGS PLC 17.32%SNDX : SYNDAX PHARMACEUTICALS INC 18.26%LXRX : LEXICON PHARMACEUTICALS INC 22.33%OCUL : OCULAR THERAPEUTIX INC 87.02%WVE : WAVE LIFE SCIENCES LTD 82.61%SCPH : SCPHARMACEUTICALS INC 50.85%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for INTELLIA THERAPEUTICS INC is calculated as follows: CashnEq [ $ 179.75M ] / Assets [ $ 458.56M ]
(=) Cash to Assets [ 39.2% ]

NTLA - Cash to Assets Ratio, Last 5 years

9.53%

Minimum

Dec 31, 2021

39.2%

Maximum

Sep 30, 2020

17.7%

Average

14.77%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.83% with a standard deviation of 9.6%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.89%
average9.83%
median6.44%
std9.6%